News by Subject Medicine & Health

Researchers at the Beckman Institute have developed a new variation of an infrared microscope with analytical capabilities, rendering it effective for probing the chemical conformations of biomolecules. Their work was published in Analytical Chemistry and featured on the cover.

A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a new inhibitor that makes drug-resistant tumour cells respond again to chemotherapy. The new substance blocks a protein in the cancer cells that normally transports the cancer drugs back out of the cells. The results were published in the scientific journal "Molecules".

The use of CAR T-cells reprogrammed to 'recognize' Cryptococcus spp. proved effective to combat the infection in vitro and in mice.

At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows. Researchers say this indirectly amplifies the attack on foreign microbes or the body's own tissues.

A team of researchers led by Professor Monica Olvera de la Cruz developed a theoretical model to design a soft material that demonstrates autonomous oscillating properties that mimic biological functions, like heartbeat.

A team of researchers from Finland and Germany have found a way to study the endonuclease-driven digestion of drug-loaded DNA nanostructures in real time. As the team investigated the binding of Dox to the DNA structures in great detail, they discovered that the majority of previous studies have vastly overestimated the anti-cancer drug doxorubicin loading capacity of DNA origami.